The common femoral artery: from open to endo

Tackle the controversial realm of common femoral artery (CFA) interventions in this PVI 2023 session. Consider endovascular treatments for CFA and examine specific situations where non-operable patients benefit from endovascular techniques. Uncover the golden standard—common femoral endarterectomy—and its safety considerations. Conclude by exploring CFA bifurcation treatment through scaffolding.

Koen Deloose

Dendermonde, Belgium

Hospital: AZ Sint Blasius

Yann Gouëffic

Hospital: Paris Saint-Joseph, France

Professor of Vascular Surgery
President of the association of the french university hospitals for clinical research

Conflicts of interest:

Research funding from Predisurge, Biotronik, WL Gore, GE Healthcare
Honoraria from Abbott, BD, Bentely, Biotronik, Boston Scientific, Cook, Eclevar Medtech, GE Healthcare, Ivascular, Medtronic, Penumbra, Sensome, Shockwave medical, WL Gore (consulting, medical advisory board, educational course, speaking)